Design, synthesis and biological evaluation of 3-(imidazo[1,2-a]pyrazin-3-ylethynyl)-2-methylbenzamides as potent and selective pan-tropomyosin receptor kinase (TRK) inhibitors.
Sign Up to like & getrecommendations! Published in 2019 at "European journal of medicinal chemistry"
DOI: 10.1016/j.ejmech.2019.06.064
Abstract: A series of 3-(imidazo[1,2-a]pyrazin-3-ylethynyl)-2-methylbenzamides was designed and synthesized as new tropomyosin receptor kinases (Trks) inhibitors by utilizing a structure-guided optimization strategy. One of the most potent compounds 9o suppressed TrkA/B/C with IC50 values of 2.65,… read more here.
Keywords: pyrazin ylethynyl; imidazo pyrazin; tropomyosin receptor; ylethynyl methylbenzamides ... See more keywords
Regioselective Syntheses of Imidazo[4,5-b]pyrazin-2-ylidene-Based Chelates and Blue Emissive Iridium(III) Phosphors for Solution-Processed OLEDs.
Sign Up to like & getrecommendations! Published in 2022 at "Inorganic chemistry"
DOI: 10.1021/acs.inorgchem.2c00750
Abstract: Six homoleptic Ir(III) complexes bearing imidazo[4,5-b]pyrazin-2-ylidene chelates were successfully designed and synthesized. Narrowband blue emission (λmax = 466-485 nm) and broadened green emission (λmax = 518-532 nm) in degassed toluene solution with high photoluminescent quantum… read more here.
Keywords: solution processed; emission; iii; pyrazin ylidene ... See more keywords
Discovery of Novel Benzo[4,5]imidazo[1,2-a]pyrazin-1-amine-3-amide-one Derivatives as Anticancer Human A2A Adenosine Receptor Antagonists.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of medicinal chemistry"
DOI: 10.1021/acs.jmedchem.2c00101
Abstract: The blockade of A2A adenosine receptor (A2AAR) activates immunostimulatory response through regulating signaling in tumor microenvironment. Thus, A2AAR has been proposed as a promising target for cancer immunotherapy. In this work, we designed a new… read more here.
Keywords: a2a adenosine; adenosine; benzo imidazo; pyrazin amine ... See more keywords